SMN2 and spinal muscular atrophy, type 1: Furthermore, in the PNCR [20] dataset, the cohort of patients with three copies of the SMN2 gene included some patients with type 1 SMA; in NHS clinical practice, patients with type 1 SMA may be eligible for [25] and receive treatment with onasemnogene abeparvovec, rather than BSC.